Stock Comparison
TEVA vs ZTS
Teva Pharma Industries Ltd ADR and Zoetis Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$41.60B
$30.42B
P/E (TTM)
59.5
12.0
Forward P/E
17.2
10.8
Price/Sales
2.4
3.2
Price/Book
5.4
9.7
EV/EBITDA
20.9
9.5
Dividend Yield
—
2.06%
Profitability
Net Margin
9.02%
27.79%
Operating Margin
13.19%
37.57%
Return on Equity
9.69%
64.90%
Return on Assets
5.13%
15.30%
Growth (YoY)
Revenue Growth
-0.80%
-0.20%
Earnings Growth
72.20%
1.20%
Price & Risk
Beta
0.9
0.7
52-Week High
$36.74
$154.88
52-Week Low
$17.54
$71.88
Analyst Target
$41.20
$108.38
Compare TEVA and ZTS your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.